Bipolar II
Resources for Patients and Caregivers
A type of bipolar disorder characterized by depressive and hypomanic episodes.
It involves at least one depressive episode lasting at least two weeks and at least one hypomanic episode lasting at least four days.
Depressive symptoms include sadness or hopelessness. Hypomanic symptoms include a persistently elevated or irritable mood.
Treatment includes counseling and medications, such as mood stabilizers.
Cluster Number:
Wiki Number: 09-Bipolar II
Diagnosis: One or more long sessions of depression, some hypo(lower)mania, but no full manic session
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: May be more chronic and recurring in the depressive phase than Bipolar I.
Progression: May be a high risk of suicide. 25-50% of Bipolar II patients make at least one suicide attempt.
Causes:
Medications: Can be modified by several medications.
Therapies:
Youtube Video: Bipolar 1 or Bipolar 2 Disorder – Which is Worse?
Amazon or Library Book: Bipolar II Disorder Workbook
Click the book to link or order from Amazon.
Support Group: dsballiance.org; 800-326-3632
(Depression and Bipolar Support Alliance)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Proposed biosensor for the detection of Bovine Serum Albumin using 7CB liquid crystals: A preliminary studyby Athul Satya on December 19, 2024
Liquid crystal (LC) based biosensors offer a sensitive platform for detecting biomolecules due to their ability to respond to molecular interactions through changes in LC orientations. In this paper, we introduce a novel LC biosensor using 4-heptyl-4-biphenyl carbonitrile (7CB) to detect Bovine Serum Albumin (BSA). The interaction between BSA and 7CB was investigated using polarising optical microscopy (POM), molecular docking (MD), and Raman spectroscopy. Time, temperature, and...
- Electrodialysis with Bipolar Membranes to valorise saline waste streams: Analysing the fate of valuable minor elementsby Julio Lopez on December 18, 2024
Brine mining can represent a valuable non-conventional resource for the extraction of Mg, Li, B, Sr and other Trace Elements (TEs) such as Rb, Cs, whose recoveries require chemical reagents such as alkaline and acidic solutions. In a circular strategy, these required chemicals can be produced in-situ through Electrodialysis with Bipolar Membranes (EDBM). In this work, a laboratory EDBM unit was operated using real brines from Trapani saltworks to investigate, for the first time, the migration of...
- Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depressionby Zixuan Guo on December 18, 2024
The relationships of the gut microbiota-inflammation-brain axis in depressive bipolar disorder (BD) remains under-elaborated. Sixty-five unmedicated depressive patients with BD II and 58 controls (HCs) were prospectively enrolled. Resting-state functional MRI data of static and dynamic amplitude of low-frequency fluctuation (ALFF) was measured, and abnormal ALFF masks were subsequently set as regions of interest to calculate whole-brain static functional connectivity (sFC) and dynamic functional...
- Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysisby Marco Solmi on December 18, 2024
Tardive Dyskinesia (TD) can occur in people exposed to dopamine receptor antagonists (DRAs). Its clinical management remains challenging. We conducted a systematic review/random-effects network meta-analysis (NMA) searching PubMed/MEDLINE/PsycINFO/ClinicalTrials.gov/Cochrane Central Register (22/05/2023, pre-defined protocol https://osf.io/b52ae/ ), for randomized controlled trials (RCTs) of pharmacological/brain stimulation interventions for DRA-induced TD in adults with schizophrenia or mood...